NEA Management Company as of Sept. 30, 2016
Portfolio Holdings for NEA Management Company
NEA Management Company holds 39 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 46.2 | $1.0B | 10M | 100.24 | |
| Ardelyx (ARDX) | 8.2 | $182M | 14M | 12.94 | |
| Dermira | 5.3 | $119M | 3.5M | 34.00 | |
| Groupon | 4.6 | $103M | 20M | 5.15 | |
| Senseonics Hldgs (SENS) | 4.6 | $103M | 26M | 3.90 | |
| Adaptimmune Therapeutics (ADAP) | 3.1 | $70M | 9.9M | 7.05 | |
| Nevro (NVRO) | 3.1 | $69M | 660k | 104.39 | |
| Epizyme | 2.8 | $62M | 6.3M | 9.84 | |
| Glycomimetics (GLYC) | 2.8 | $61M | 8.6M | 7.15 | |
| Proteostasis Therapeutics In | 2.5 | $56M | 3.6M | 15.59 | |
| Lexicon Pharmaceuticals (LXRX) | 1.9 | $43M | 2.4M | 18.07 | |
| Clovis Oncology | 1.8 | $41M | 1.1M | 36.05 | |
| Loxo Oncology | 1.5 | $34M | 1.3M | 26.18 | |
| Care | 1.5 | $33M | 3.3M | 9.96 | |
| Endologix | 1.4 | $32M | 2.5M | 12.80 | |
| Aerohive Networks | 1.3 | $29M | 4.7M | 6.09 | |
| Trevena | 1.1 | $26M | 3.8M | 6.75 | |
| Achaogen | 1.0 | $23M | 4.7M | 4.79 | |
| Cascadian Therapeutics | 0.8 | $18M | 11M | 1.64 | |
| Tracon Pharmaceuticals | 0.6 | $13M | 1.9M | 6.67 | |
| Rigel Pharmaceuticals (RIGL) | 0.5 | $12M | 3.2M | 3.67 | |
| Strongbridge Bioph shs usd | 0.5 | $11M | 2.1M | 5.22 | |
| AVEO Pharmaceuticals | 0.4 | $9.2M | 10M | 0.89 | |
| Aurinia Pharmaceuticals (AUPH) | 0.3 | $7.7M | 2.5M | 3.01 | |
| Mirna Therapeutics | 0.3 | $5.9M | 3.0M | 1.97 | |
| Sunesis Pharmaceuticals Inc Ne | 0.2 | $5.7M | 1.3M | 4.37 | |
| Dasan Zhone Solutions | 0.2 | $5.5M | 4.8M | 1.14 | |
| ArQule | 0.2 | $4.5M | 2.5M | 1.79 | |
| Arca Biopharma | 0.2 | $4.1M | 1.5M | 2.83 | |
| Akari Therapeutics | 0.2 | $3.8M | 452k | 8.51 | |
| Champions Oncology (CSBR) | 0.1 | $2.6M | 1.6M | 1.68 | |
| Cerecor | 0.1 | $2.5M | 595k | 4.23 | |
| Roka Bioscience | 0.1 | $2.2M | 3.2M | 0.69 | |
| Xtera Communications | 0.1 | $2.0M | 3.6M | 0.55 | |
| Zosano Pharma | 0.1 | $1.6M | 2.1M | 0.78 | |
| Orexigen Therapeutics | 0.1 | $1.2M | 371k | 3.32 | |
| Agile Therapeutics | 0.0 | $932k | 134k | 6.98 | |
| Paratek Pharmaceuticals | 0.0 | $862k | 66k | 13.01 | |
| Catalyst Biosciences | 0.0 | $789k | 652k | 1.21 |
